跳至主要内容
临床试验/NCT03352518
NCT03352518已完成不适用

Performance Characteristics and Safety Assessment of a Non-invasive Glucose Monitoring Device

RSP Systems A/S2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2017年12月28日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
10
试验地点
2
主要终点
Generation and validation of predictive calibration models

研究概览

简要总结

This clinical study has been launched to collect spectral raman data paired with validated glucose reference values in private homes of subjects.

详细描述

Subjects will collect spectral raman data on device every 15 minutes for 10 hours a day for five days. The five days will be distributes with in a timeframe of ten days. A Flash Glucose Monitor will be used as a comparator. In addition to this, four daily capillary Blood Glucose readings will be collected.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female subjects 18 years of age or older
  • Diabetic patients (all types)

排除标准

  • Pregnant women
  • Subjects not able to understand and read Danish
  • In investigator's opinion, subject is not able to follow instructions as specified in the protocol
  • Subjects not able to hold hand/arm steadily
  • Extensive skin changes, tattoos or diseases on probe application site
  • Known allergy to medical grade alcohol used to disinfect skin

研究组 & 干预措施

IMD data collection

Experimental

Subjects will intensively collect spectral raman data in a home-based setting for 5 days using WM3.4NR and comparators.

干预措施: WM3.4NR (Device)

结局指标

主要结局

Generation and validation of predictive calibration models

时间窗: 3 months

The collected data will generate individual calibration models capable of predicting tissue glucose concentrations. An evaluation of the models by the consensus error grid will be performed.

次要结局

  • Safety assessment of the intervention by the paucity of adverse events(3 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验